All Cosmos Bio-Tech Holding Corporation
TWSE:4148.TW
52.2 (TWD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,826.587 | 3,702.33 | 2,197.323 | 1,642.783 | 1,767.699 | 2,687.581 | 2,263.652 | 2,065.543 | 2,257.308 | 2,231.231 | 1,874.852 | 1,804.681 | 1,404.531 |
| Cost of Revenue
| 2,260.704 | 2,564.754 | 1,602.958 | 1,270.636 | 1,374.387 | 1,912.987 | 1,512.131 | 1,410.123 | 1,634.421 | 1,662.884 | 1,435.059 | 1,313.101 | 1,002.834 |
| Gross Profit
| 565.883 | 1,137.576 | 594.365 | 372.147 | 393.312 | 774.594 | 751.521 | 655.42 | 622.887 | 568.347 | 439.793 | 491.58 | 401.697 |
| Gross Profit Ratio
| 0.2 | 0.307 | 0.27 | 0.227 | 0.222 | 0.288 | 0.332 | 0.317 | 0.276 | 0.255 | 0.235 | 0.272 | 0.286 |
| Reseach & Development Expenses
| 3.731 | 2.277 | 3.851 | 2.541 | 4.655 | 6.587 | 4.456 | 5.855 | 6.09 | 7.908 | 17.98 | 13.636 | 13.038 |
| General & Administrative Expenses
| 236.166 | 229.117 | 178.217 | 153.014 | 157.924 | 187.302 | 184.35 | 169.649 | 178.935 | 196.286 | 154.999 | 127.86 | 95.291 |
| Selling & Marketing Expenses
| 160.186 | 246.451 | 199.562 | 121.509 | 110.34 | 197.888 | 155.994 | 155.318 | 153.951 | 187.373 | 127.203 | 148.067 | 0 |
| SG&A
| 372.257 | 475.568 | 377.779 | 274.523 | 268.264 | 385.19 | 340.344 | 324.967 | 332.886 | 383.659 | 282.202 | 275.927 | 95.291 |
| Other Expenses
| 35.956 | -27.651 | 41.763 | 33.896 | 40.19 | 60.932 | 13.731 | 30.269 | 0 | 0 | 0 | 1.153 | 122.429 |
| Operating Expenses
| 375.988 | 477.845 | 381.63 | 277.064 | 272.919 | 391.777 | 344.8 | 330.822 | 338.976 | 391.567 | 300.182 | 289.563 | 230.758 |
| Operating Income
| 189.895 | 645.499 | 265.616 | 146.483 | 160.428 | 443.729 | 420.452 | 354.867 | 283.911 | 176.78 | 139.611 | 217.131 | 270.867 |
| Operating Income Ratio
| 0.067 | 0.174 | 0.121 | 0.089 | 0.091 | 0.165 | 0.186 | 0.172 | 0.126 | 0.079 | 0.074 | 0.12 | 0.193 |
| Total Other Income Expenses Net
| 62.39 | -11.549 | 55.969 | 3.188 | -56.61 | -44.714 | -13.517 | -24.313 | -60.694 | 5.612 | -2.091 | -8.86 | -111.284 |
| Income Before Tax
| 252.285 | 633.95 | 321.585 | 149.671 | 103.818 | 399.015 | 406.935 | 330.554 | 223.217 | 182.392 | 137.52 | 208.271 | 159.583 |
| Income Before Tax Ratio
| 0.089 | 0.171 | 0.146 | 0.091 | 0.059 | 0.148 | 0.18 | 0.16 | 0.099 | 0.082 | 0.073 | 0.115 | 0.114 |
| Income Tax Expense
| 68.321 | 177.931 | 84.931 | 51.503 | 65.14 | 50.328 | 10.512 | 38.29 | 7.067 | 7.183 | 2.739 | 0.494 | -1.929 |
| Net Income
| 139.361 | 368.204 | 198.128 | 82.204 | 35.694 | 305.058 | 322.873 | 243.217 | 197.064 | 195.639 | 158.476 | 210.36 | 162.321 |
| Net Income Ratio
| 0.049 | 0.099 | 0.09 | 0.05 | 0.02 | 0.114 | 0.143 | 0.118 | 0.087 | 0.088 | 0.085 | 0.117 | 0.116 |
| EPS
| 2.18 | 5.75 | 3.09 | 1.28 | 0.56 | 4.76 | 5.31 | 4.3 | 3.52 | 3.78 | 3.17 | 4.21 | 3.25 |
| EPS Diluted
| 2.13 | 5.65 | 3.09 | 1.28 | 0.56 | 4.75 | 5.3 | 4.25 | 3.48 | 3.76 | 3.17 | 4.21 | 3.25 |
| EBITDA
| 239.042 | 694.511 | 314.208 | 196.638 | 213.673 | 489.944 | 461.29 | 408.754 | 331.646 | 226.501 | 182.783 | 246.931 | 295.67 |
| EBITDA Ratio
| 0.085 | 0.188 | 0.143 | 0.12 | 0.121 | 0.182 | 0.204 | 0.198 | 0.147 | 0.102 | 0.097 | 0.137 | 0.211 |